The activation of this checkpoint requires the relocalization into nuclear foci and the stepwise activation of proteins of the ATR-Chk1 and the Fanconi Anemia (FA) pathways [11], including Topoisomerase II Binding Protein 1 (TopBP1) and FANCD2 [12–15]. The gene discussed is FANCD2; the disease is Friedreich ataxia.